Cincinnati, OH, United States of America

Michiaki Inoue

This inventor holds 5 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Kao Corporation. Active years: 2015-2018.

USPTO Granted Patents = 5 

% Patents Active = 60.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Michiaki Inoue: Innovator in Odor Inhibition Technologies

Introduction

Michiaki Inoue is a notable inventor based in Cincinnati, OH (US). He has made significant contributions to the field of odor inhibition, holding a total of 5 patents. His work focuses on innovative solutions to reduce unpleasant odors, particularly those associated with pyrazine derivatives and Furaneol.

Latest Patents

Inoue's latest patents include an agent for inhibiting the odor of pyrazine derivatives. This invention provides a solution for reducing odors based on olfactory receptor antagonism. The agent includes at least one antagonist of olfactory receptor OR5K1 as an active ingredient. Another significant patent is an inhibitor of odor caused by Furaneol. This substance inhibits the odor caused by 2,5-dimethyl-4-hydroxy-3(2H)-furanone, comprising a substance that inhibits the response of olfactory receptor OR5K1 as an active ingredient.

Career Highlights

Michiaki Inoue is currently employed at Kao Corporation, where he continues to develop innovative solutions in the field of odor control. His work has garnered attention for its practical applications in various industries.

Collaborations

Inoue collaborates with talented coworkers, including Naoko Saito and Aya Namba, contributing to a dynamic research environment that fosters innovation.

Conclusion

Michiaki Inoue's contributions to odor inhibition technologies highlight his role as a leading inventor in this specialized field. His innovative patents reflect a commitment to improving everyday experiences through scientific advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…